This drug company could deliver a 72% gain in immediate income

A Big Income Trade in a Drug Company. Recently, a news report about a biotech company noted "A rejection of its experimental pain drug forced [this company] to dump the program.

You're receiving this email because you are subscribed to Options Profits Daily, if you no longer wish to receive these emails you can unsubscribe here.

` This Trade Risks About $310 for a Potential Gain of 93% Recently, a news report about a biotech company noted "A rejection of its experimental pain drug forced [this company] to dump the program. [SPONSORED CONTENT] How to Retire Starting With $20 Bill O'Reilly and a legendary stock picker just revealed the only way to retire rich starting with $20. Details here. In a rare indisputable rejection, two Food and Drug Administration advisory committees voted 27-0 to recommend that the FDA not approve the San Francisco company's oxycodegol, a slow-acting opioid aimed at chronic lower back pain." The company was disappointed by the news and argued the drug didn't addict people initially seeking pain relief or cause the quick euphoria that drug abusers seek. But, "one advisory committee member wanted more data from the company about what would happen if someone tried to inhale or inject the drug" while "others were concerned that approval would imply that oxycodegol was a "safer" opioid." The market reaction to the news creates an income opportunity for options traders. Using recent market data, this company could be positioned to deliver a gain of more than 70% to short term traders as we explain in our latest article. These gains are in the form of immediate income and the trade uses options so there is a certain expiration date, and a defined level of risk. This gain is also based on recent market data rather than a hypothetical example. We also show not only the potential gains based on actual market data, we also define the risk in dollar terms with actual market data. You will also see how to do this calculation so you can determine risks and rewards as market prices change. The complete details of the strategy and the specific trade idea are in our latest free educational article that is available right here. YOU PROBABLY MISSED THIS:    How to Retire Starting With $20      Two Off-the-Radar Dividend Plays      Boeing's Problems Offer Triple Digit Potential In This Company      Two Mega Banks Worth Buying Now

Not sure the best way to get started? Follow these simple steps to hit the ground running. › Step #1 - Get These FREE Reports: The Ultimate Guide to Options | 7 Cheap and Good Stocks to Buy | 10 Great Stocks Under $10   › Step #2 - Join Our Premium Advisories: Options Cash Cow | The Next Superstock | Triple Digit Returns   › Step #3 - Connect With The Community: Trading Tips Official Facebook Group Nothing in this email should be considered personalized financial advice. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing The Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions. As defined in the United States Securities Act of 1933 Section 27(a), as amended in the Securities Exchange Act of 1934 Section 21(e), statements in this communication which are not purely historical are forward-looking statements and include statements regarding beliefs, plans, intent, predictions or other statements of future tense. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

This email was sent to phanphuongthanh89.822152@blogger.com by editor@optionsprofitsdaily.com OptionsProfitsDaily.com | 3435 Ocean Park Blvd. Suite 107-334 Santa Monica, CA 90405 unsubscribe | report SPAM